Olema Pharmaceuticals, Inc.
OLMA
$13.59
-$0.23-1.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 25.51M | 21.00M | 18.61M | 17.08M | 17.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 191.81M | 168.70M | 155.38M | 147.13M | 142.79M |
| Operating Income | -191.81M | -168.70M | -155.38M | -147.13M | -142.79M |
| Income Before Tax | -185.15M | -162.45M | -149.96M | -142.30M | -128.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -185.15 | -162.45 | -149.96 | -142.30 | -128.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -185.15M | -162.45M | -149.96M | -142.30M | -128.89M |
| EBIT | -191.81M | -168.70M | -155.38M | -147.13M | -142.79M |
| EBITDA | -191.33M | -168.21M | -154.96M | -146.66M | -142.36M |
| EPS Basic | -2.03 | -1.86 | -1.87 | -1.98 | -2.01 |
| Normalized Basic EPS | -1.19 | -1.09 | -1.10 | -1.17 | -1.26 |
| EPS Diluted | -2.03 | -1.86 | -1.87 | -1.98 | -2.01 |
| Normalized Diluted EPS | -1.19 | -1.09 | -1.10 | -1.17 | -1.26 |
| Average Basic Shares Outstanding | 365.35M | 347.97M | 322.45M | 293.98M | 264.76M |
| Average Diluted Shares Outstanding | 365.35M | 347.97M | 322.45M | 293.98M | 264.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |